GlassScriptPhysician profile
Michael S Friedman
NPI 1285692517
$7,700.06
in general payments reported to CMS, 2019-2025
35 companies · $930 in 2025
The $930 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $840 · 2021: $1,091 · 2022: $711 · 2023: $1,217 · 2024: $1,263 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,409.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,305.12 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,044.46 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $860.11 | 2019-2025 | Farxiga, Brilinta |
| Amgen INC. | $688.74 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $536.91 | 2019-2024 | Xarelto |
| Pfizer INC. | $505.40 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $325.13 | 2021-2025 | Verquvo, Capvaxive |
| Alnylam Pharmaceuticals INC. | $296.91 | 2019-2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $267.54 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $239.29 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $215.94 | 2023-2024 | Onyx Frontier, Linq II, Telescope |
| Bayer Healthcare Pharmaceuticals INC. | $127.97 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.58 | 2019-2024 | Jardiance |
| Edwards Lifesciences Corporation | $90.31 | 2023-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Shockwave Medical, INC | $89.66 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $80.67 | 2019-2023 | Injectafer |
| Vifor Pharma, INC. | $80.40 | 2019-2021 | |
| Irhythm Technologies, INC. | $76.17 | 2019-2023 | Zio Xt Patch |
| Cook Medical LLC | $70.98 | 2019-2025 | Zenith Alpha |
| Gilead Sciences, INC. | $70.57 | 2019 | |
| Boston Scientific Corporation | $68.75 | 2023 | Watchman Access System, Watchman |
| Kiniksa Pharmaceuticals International, Plc | $65.38 | 2024 | Arcalyst |
| Biotronik INC. | $62.22 | 2019 | |
| Abbott Laboratories | $62.02 | 2020-2023 | Amplatzer |
| Abiomed | $60.78 | 2021-2023 | Impella |
| Regeneron Healthcare Solutions, INC. | $50.66 | 2019 | |
| Medtronic Vascular, INC. | $46.39 | 2019-2020 | |
| Chiesi USA, INC. | $38.28 | 2019-2022 | |
| Scpharmaceuticals INC. | $30.74 | 2024 | |
| Philips North America LLC | $30.04 | 2024 | (P88) Igt Devices Fm |
| Astellas Pharma US INC | $28.02 | 2019 | |
| Amarin Pharma, INC. | $20.22 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $15.90 | 2024 | |
| W. L. Gore & Associates, INC. | $15.62 | 2024 | Gore Cardioform Septal Occluder |
| Kowa Pharmaceuticals America, INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.